Cerity Partners LLC Makes New $34,000 Investment in agilon health, inc. (NYSE:AGL)

Cerity Partners LLC acquired a new stake in agilon health, inc. (NYSE:AGL) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 18,156 shares of the company’s stock, valued at approximately $34,000.

A number of other hedge funds and other institutional investors have also modified their holdings of AGL. Symphony Financial Services Inc. raised its holdings in agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares in the last quarter. Signaturefd LLC grew its position in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Oak Thistle LLC acquired a new stake in agilon health during the 4th quarter worth $25,000. Ieq Capital LLC purchased a new stake in agilon health in the fourth quarter valued at $26,000. Finally, Blair William & Co. IL boosted its stake in agilon health by 6.4% in the fourth quarter. Blair William & Co. IL now owns 254,759 shares of the company’s stock valued at $484,000 after acquiring an additional 15,409 shares in the last quarter.

agilon health Price Performance

Shares of NYSE:AGL opened at $3.89 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a 50-day moving average price of $4.19 and a 200 day moving average price of $3.14. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The company has a market cap of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38.

Analyst Ratings Changes

A number of analysts have recently commented on AGL shares. Sanford C. Bernstein upgraded agilon health from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Stifel Nicolaus boosted their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada raised their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. TD Cowen upped their price target on shares of agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a research report on Tuesday, April 15th. Finally, Robert W. Baird decreased their price target on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company. According to data from MarketBeat, agilon health has a consensus rating of “Hold” and a consensus target price of $4.81.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.